Companies / Kuwait
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Free Pricing Of OTCs Backfires
February 2007 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
OTC market growth is likely to be steady as a result of overall healthcare sector development. Low-income consumers will remain reliant on OTC drugs as a cost-effective way of meeting their treatment needs. The dominance of the prescription market is unlikely to change in the near future, with the OTC share of total sales forecast to fall to 16.8% by 2010.